Definium Therapeutics, Inc.: common_shares_outstanding

Value{"unit": "shares", "value": 76774057, "concept": "us-gaap:CommonStockSharesOutstanding"}
Period (as of 2025-09-30)
Statuscurrent
EntityDefinium Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-25-269596 · Open the official SEC filing →
Retrieved: 2026-08-19T18:15:04.856374+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001813814/common-shares-outstanding/2025-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/8baec2cf-39df-43cc-95b3-0d66d38b039e

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies